Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 4.36
(3.32%)
CNY 4.36
(3.32%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 357.24 Million CNY | 14.02% |
| 2022 | 313.3 Million CNY | -6.26% |
| 2021 | 334.24 Million CNY | -14.35% |
| 2020 | 390.23 Million CNY | 432.3% |
| 2019 | 73.31 Million CNY | -41.51% |
| 2018 | 125.33 Million CNY | 781.42% |
| 2017 | -18.39 Million CNY | 71.3% |
| 2016 | -64.09 Million CNY | 64.59% |
| 2015 | -181.02 Million CNY | 82.66% |
| 2014 | -1.04 Billion CNY | -0.37% |
| 2013 | -1.03 Billion CNY | 8.95% |
| 2012 | -1.14 Billion CNY | -6.92% |
| 2011 | -1.06 Billion CNY | 26.31% |
| 2010 | -1.44 Billion CNY | -1472.35% |
| 2009 | -92.19 Million CNY | -28.96% |
| 2008 | -71.49 Million CNY | -31.84% |
| 2007 | -54.22 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 422.5 Million CNY | 1.76% |
| 2024 Q1 | 415.17 Million CNY | 16.22% |
| 2024 Q3 | 323.67 Million CNY | -23.39% |
| 2023 Q2 | 309.76 Million CNY | -7.51% |
| 2023 FY | 357.24 Million CNY | 14.02% |
| 2023 Q4 | 357.24 Million CNY | 0.86% |
| 2023 Q3 | 354.2 Million CNY | 14.35% |
| 2023 Q1 | 334.93 Million CNY | 6.9% |
| 2022 Q3 | 350.18 Million CNY | -9.2% |
| 2022 Q4 | 313.3 Million CNY | -10.53% |
| 2022 FY | 313.3 Million CNY | -6.26% |
| 2022 Q1 | 420.56 Million CNY | 25.82% |
| 2022 Q2 | 385.66 Million CNY | -8.3% |
| 2021 Q2 | 506.73 Million CNY | 23.62% |
| 2021 Q4 | 334.24 Million CNY | 13.11% |
| 2021 FY | 334.24 Million CNY | -14.35% |
| 2021 Q1 | 409.89 Million CNY | 5.04% |
| 2021 Q3 | 295.51 Million CNY | -41.68% |
| 2020 Q2 | 263.72 Million CNY | 3.83% |
| 2020 Q3 | 314.58 Million CNY | 19.28% |
| 2020 Q4 | 390.23 Million CNY | 24.05% |
| 2020 FY | 390.23 Million CNY | 432.3% |
| 2020 Q1 | 254 Million CNY | 246.47% |
| 2019 Q3 | 178.5 Million CNY | 566.7% |
| 2019 Q2 | 26.77 Million CNY | -66.25% |
| 2019 FY | 73.31 Million CNY | -41.51% |
| 2019 Q1 | 79.32 Million CNY | -36.71% |
| 2019 Q4 | 73.31 Million CNY | -58.93% |
| 2018 Q3 | 75.6 Million CNY | 137.07% |
| 2018 Q1 | -3.66 Million CNY | 80.07% |
| 2018 Q2 | -203.93 Million CNY | -5462.41% |
| 2018 Q4 | 125.33 Million CNY | 65.77% |
| 2018 FY | 125.33 Million CNY | 781.42% |
| 2017 Q3 | -268.88 Million CNY | -1891.58% |
| 2017 FY | -18.39 Million CNY | 71.3% |
| 2017 Q4 | -18.39 Million CNY | 93.16% |
| 2017 Q2 | -13.5 Million CNY | 88.9% |
| 2017 Q1 | -121.64 Million CNY | -89.78% |
| 2016 Q2 | -60.08 Million CNY | 80.54% |
| 2016 Q1 | -308.72 Million CNY | -70.55% |
| 2016 FY | -64.09 Million CNY | 64.59% |
| 2016 Q4 | -64.09 Million CNY | 73.12% |
| 2016 Q3 | -238.43 Million CNY | -296.86% |
| 2015 Q3 | -190.48 Million CNY | 23.83% |
| 2015 Q4 | -181.02 Million CNY | 4.97% |
| 2015 Q1 | -276.94 Million CNY | 73.47% |
| 2015 FY | -181.02 Million CNY | 82.66% |
| 2015 Q2 | -250.08 Million CNY | 9.7% |
| 2014 FY | -1.04 Billion CNY | -0.37% |
| 2014 Q4 | -1.04 Billion CNY | -2.59% |
| 2014 Q3 | -1.01 Billion CNY | 2.97% |
| 2014 Q2 | -1.04 Billion CNY | -1.45% |
| 2014 Q1 | -1.03 Billion CNY | 0.62% |
| 2013 Q3 | -1.1 Billion CNY | 0.12% |
| 2013 Q4 | -1.03 Billion CNY | 6.1% |
| 2013 FY | -1.03 Billion CNY | 8.95% |
| 2013 Q1 | -1.12 Billion CNY | 1.71% |
| 2013 Q2 | -1.1 Billion CNY | 1.22% |
| 2012 Q3 | -1.07 Billion CNY | -7.68% |
| 2012 Q4 | -1.14 Billion CNY | -5.85% |
| 2012 Q2 | -1 Billion CNY | -0.29% |
| 2012 FY | -1.14 Billion CNY | -6.92% |
| 2012 Q1 | -999.16 Million CNY | 6.47% |
| 2011 FY | -1.06 Billion CNY | 26.31% |
| 2011 Q2 | -1.28 Billion CNY | 12.88% |
| 2011 Q3 | -1.11 Billion CNY | 13.3% |
| 2011 Q4 | -1.06 Billion CNY | 4.26% |
| 2011 Q1 | -1.47 Billion CNY | -1.9% |
| 2010 Q4 | -1.44 Billion CNY | 8.37% |
| 2010 Q3 | -1.58 Billion CNY | -1.78% |
| 2010 Q1 | -105.8 Million CNY | -14.76% |
| 2010 Q2 | -1.55 Billion CNY | -1369.11% |
| 2010 FY | -1.44 Billion CNY | -1472.35% |
| 2009 FY | -92.19 Million CNY | -28.96% |
| 2009 Q4 | -92.19 Million CNY | 0.0% |
| 2008 FY | -71.49 Million CNY | -31.84% |
| 2007 FY | -54.22 Million CNY | 0.0% |